It says continue to see what happens with secondary endpoints.
But it says that despite continuation they won't meet primary endpoints.
Very disappointing.
I wonder what will happen with Novartis
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-27
-
- There are more pages in this discussion • 1,049 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.030(2.63%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.11 | $4.207M | 3.674M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 98285 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 11788 | 5 |
View Market Depth
| Last trade - 11.35am 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |